Zurich Insurance: Good Operating Performance Seems To Be Priced-In Following Q1 Sales Update

2025-05-11 04:09:56 ET

Summary

• Zurich's recent financial performance has been strong, with earnings growth, profitability, and capital ratios exceeding targets, leading to increased medium-term goals for 2025-27.
• The company has shown robust growth in P&C and Life segments, with significant improvements in operating earnings and a strong capital position supporting dividend growth.
• Despite positive trends, Zurich's high valuation, trading at 3.9x book value and 15.6x forward earnings, suggests overvaluation compared to peers like AXA and Allianz.
• Given the high valuation and potential revenue growth concerns in the U.S. P&C lines, Zurich is currently rated as a 'hold.'

As I’ve covered in previous articles , I see Zurich’s ( ZURVY )(ZFSVF) investment case to be mainly geared toward income, as the company offers an interesting dividend yield, but its valuation is somewhat high. In this article, I review its most recent financial performance and update its investment case, to see if it now offers more value for long-term investors or not....

Read the full article on Seeking Alpha

For further details see: